MYP_001048
Basic Information
Unnamed
Anticancer
Immunology Immunomodulation Immunogenic
Standard
9 amino acids
C50H94N18O12
Standard
Sequence
RQKRILVNL
Physicochemical Analysis
1139.39 Da
12.00
2.76
2.55
0.3066
-0.40
0.54
-0.40
87.91
162.22
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
532.12
-4.13
19.0
15.0
41.0
80.0
0.0
10.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0018600 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
non-small cell lung cancer; HLA-B*15:01
Flow cytometry
RECORD: Rec_0133847 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
non-small cell lung cancer; HLA-B*15:01
51Cr release
RECORD: Rec_0285208 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
non-small cell lung cancer; HLA-B*15:01
0.3333 μM
Predicted HLA-I binding